Background: Cyclins control the activation of cyclin-dependent kinases (CDK), which in turn, control cell proliferation. We have shown that the virus restriction factor SAMHD1 is controlled by CDK6, a CDK controlling early G0 to G1 transition of the cell cycle. However, the cyclin controlling the process of SAMHD1 function has not been clearly identified in primary cells.
Methods: Monocytes were isolated and transfected with siRNA against different cyclins controlling cell cycle. Transfected monocytes were differentiated in macrophages using M-CSF. RNA interference was assessed by quantitative PCR and Western blot. Primary monocyte-derived macrophages (MDM) were infected with a VSV-pseudotyped NL4-3 GFP-expressing virus or full-replicative R5 HIV-1 strain BaL. Total viral DNA formation was quantified by qPCR and HIV replication measured by flow cytometry. SAMHD1 phosphorylation and protein expression were analyzed by immunoblotting. dNTP intracellular levels in siRNA-treated MDM were determined using a polymerase-based method.
Results: RNAi of eight distinct cyclins led to efficient and specific downregulation (up to 90% efficacy) of the corresponding cyclin as compared to mock-transfected cells or cells transfected with a non-targeting siRNA in MDM. Downregulation of the CDK6-associated cyclin D3 showed the strongest inhibitory effect (p=0.0002) of HIV-1 replication and total viral DNA formation in acutely infected MDM. Cyclins D1 and E2 (associated to CDK6 and CDK2, respectively) had a lower inhibitory effect. Cyclin A2, B1, B2 and D2 did not block HIV-1 replication. Alternative siRNA sequences targeting cyclin D3 confirmed the effect of cyclin D3 in HIV-1 infection and total viral DNA formation. Cyclin D3 downregulation led to a significant (p<0.01) reduction of SAMHD1 phosphorylation (at residue T592), CDK2 activation as measured by phosphorylation of T160 and decreased intracellular dNTP levels. The effect of cyclin D3 RNA interference was lost after degradation of SAMHD1 by HIV-2 Vpx.
Conclusions: Knockdown of cyclin D3 has a major impact in SAMHD1 phosphorylation, dNTP levels and HIV-1 reverse transcription and replication. Cyclin D3 is the catalytic partner of CDK6. Thus, our results indicate a fundamental role of the CDK6-cyclin D3 complex in SAMHD1-mediated virus restriction during GO to G1 transition. Agents targeting cell proliferation may prevent new rounds of infection and hypothetically, might prevent the proliferation of persistently infected cells.